Login to Your Account

'Best of Unigene' Lands in Hands of Start-up Enteris

By Jennifer Boggs
Managing Editor

Friday, August 16, 2013

Crushing debt forced Unigene Laboratories Inc. into bankruptcy earlier this year, but its promising Peptelligence delivery technology has found a new home in start-up Enteris Biopharma Inc., which launched recently to develop oral formulations of both peptide drugs and currently injectable-only small molecules.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription